RBC Capital raises Agilent stock price target on pharma strength

Markets Investing.com By Investing.com 27 Aug 2026 13:45 1 min read
RBC Capital raises Agilent stock price target on pharma strength

Covered in this story

What has happened since

Price move measured from the close nearest publication to the latest quote.

Tracked from this story

RBC Capital Markets’s $185 target on $A is on the record and being tracked to Aug 2027 (12-month default), scored on the close that day.

RBC Capital Markets’s track record →

Call it yourself

No member calls on $A yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Agilent Technologies →
Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.